title: Peripheral Neuromodulation to Treat Postamputation Pain.
abstract: Some of the more common peripherally mediated pain disorders are postamputation stump pain and phantom pain. These disabling conditions have proven difficult to treat. Here we aim to illustrate an option to treat postamputation pain using peripheral neurostimulation techniques. Traditional peripheral neuromodulation techniques use standard stimulation parameters and work by stimulation of nerve tissues which are then felt by the patient as a tingling sensation or paresthesia. Recently introduced high-frequency (10 kHz) electrical nerve block [HFAC (high-frequency alternating current) block] via a surgically implanted peripheral nerve cuff electrode results in true conduction block which actually blocks action potentials emanating from the painful neuroma and thus suppresses pain without tingling or paresthesia felt by the patient. In a recently completed 10-patient pilot study, the average pain level decreased from a score of 5.7 to 1.4 (out of 10) after HFAC block therapy with 85% of all testing sessions yielding a >50% pain reduction; a very significant reduction in the use of opioid and other analgesics was also noted, with all tested patients either stopping or decreasing their analgesic intake significantly. Patients achieved meaningful and significant pain reduction throughout the study, and patients who had phantom pain (in addition to stump pain) that responded to local anesthetic injections also responded favorably with HFAC block, presumably because in these particular patients, the phantom symptoms were peripherally generated. Each of the tested patients reported that HFAC block provided the most significant amount of pain reduction they had ever experienced when compared to other pain modalities tried since their amputations. The high-frequency electric nerve block technique is currently investigational pending FDA clearance. The next step for this modality is a pivotal trial, with the goal of having this therapy available to the mass market upon FDA clearance.
authors.forename: Amol
authors.initials: A
authors.lastname: Soin
authors.forename: Zi-Ping
authors.initials: ZP
authors.lastname: Fang
authors.forename: Jon
authors.initials: J
authors.lastname: Velasco
mesh_terms: D000671:Amputation, Surgical / Q000009:adverse effects*; D000672:Amputation Stumps / Q000473:pathology / Q000601:surgery*; D004599:Electric Stimulation Therapy / Q000379:methods*; D006801:Humans; D059408:Pain Management / Q000379:methods*; D010525:Peripheral Nerves / Q000502:physiology / Q000601:surgery*; D011183:Postoperative Complications / Q000175:diagnosis / Q000601:surgery